Algeria vs Morocco: HIV/AIDS deaths averted by antiretroviral therapy
Algeria
1,007 deaths
in 2024
Morocco
1,213 deaths
in 2024
Algeria rank
73rd
Morocco rank
70th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Algeria
- Morocco
How they compare
Morocco currently reports 1,213 deaths against 1,007 deaths in Algeria, a difference of 206 deaths.
That makes Morocco's figure about 1.2 times Algeria's.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Morocco ahead.
Algeria ranks 73rd and Morocco ranks 70th of 157 countries.
Across the 4 decades both report, Algeria averaged higher in 1 and Morocco in 3.
Head to head by decade
| Decade | Algeria | Morocco | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 4.15 deaths | 0 deaths | 4.15 deaths | Algeria |
| 2000s | 78.66 deaths | 183.06 deaths | 104.4 deaths | Morocco |
| 2010s | 458.68 deaths | 725.97 deaths | 267.3 deaths | Morocco |
| 2020s | 900.71 deaths | 1,101 deaths | 200.19 deaths | Morocco |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Algeria or Morocco?
- Morocco, at 1,213 deaths against 1,007 deaths in Algeria as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Algeria and Morocco?
- 206 deaths, with Morocco ahead.
- How many years of comparable data are there for Algeria and Morocco?
- 35 years are reported by both, from 1990 to 2024.
- How do Algeria and Morocco rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Algeria ranks 73rd and Morocco ranks 70th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.